Browsing by Subject "angiogenesis inhibitors"
Now showing items 1-1 of 1
An activated factor VII variant with enhanced tissue factor-independent activity speeds wound healing in a mouse hemophilia B model. (J Thromb Haemost, 2016-06)UNLABELLED: Essentials Disorders of hemostasis can lead to delayed and defective wound healing. In hemophilia B (HB) mice, 7 days of Factor (F)IX or VIIa are needed to normalize wound healing. One dose of a highly active ...